Cargando…

Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?

To search whether or not the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine affects the fertility of women at the 6th months by using AMH, which is an ovarian reserve test. Our study, designed as a prospective case-control study, included 104...

Descripción completa

Detalles Bibliográficos
Autores principales: Yildiz, Elif, Timur, Burcu, Guney, Gurhan, Timur, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194489/
https://www.ncbi.nlm.nih.gov/pubmed/37335728
http://dx.doi.org/10.1097/MD.0000000000033824
_version_ 1785044026582368256
author Yildiz, Elif
Timur, Burcu
Guney, Gurhan
Timur, Hakan
author_facet Yildiz, Elif
Timur, Burcu
Guney, Gurhan
Timur, Hakan
author_sort Yildiz, Elif
collection PubMed
description To search whether or not the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine affects the fertility of women at the 6th months by using AMH, which is an ovarian reserve test. Our study, designed as a prospective case-control study, included 104 women who presented to the GOP EAH obstetrics and gynecology outpatient clinic in January and February 2022. The study group included 74 women who presented to the outpatient clinic and planned to be vaccinated and 30 women who refused to be vaccinated as the control group. Anti-COVID-19 antibody levels in all participants were checked before participation in the study, and participants who were positive were excluded from the study. Blood was taken from the participants in both control and study groups to evaluate their AMH levels before the 2 doses of vaccination. After 2 doses of the vaccine, they were called for follow-up, and serological tests were performed to check whether they were positive for anti-COVID-19 antibodies. Participants in both groups were referred for follow-up after 6 months, samples were taken again for AMH, and the data were recorded. The mean age of the study group was 27.6 ± 5.3 years, and the mean age of the control group was 28.65 ± 5.25 years (P = .298). There was no statistically significant difference between the vaccinated and nonvaccinated groups in terms of AMH levels measured at the 6th month (P = .970). When the vaccinated group was compared in terms of AMH values at the first visit before vaccination and at the 6th month after vaccination, no statistically significant difference was found between them (p:0.127) mRNA vaccination to protect against SARS-CoV-2 does not adversely affect ovarian reserve, which is an indirect indicator of fertility. mRNA vaccines continue to be the most important method of protection against epidemics. Carefully and accurately informing women who are hesitant to get vaccinated is of great importance for the success of the fight against the epidemic.
format Online
Article
Text
id pubmed-10194489
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101944892023-05-19 Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve? Yildiz, Elif Timur, Burcu Guney, Gurhan Timur, Hakan Medicine (Baltimore) 5600 To search whether or not the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine affects the fertility of women at the 6th months by using AMH, which is an ovarian reserve test. Our study, designed as a prospective case-control study, included 104 women who presented to the GOP EAH obstetrics and gynecology outpatient clinic in January and February 2022. The study group included 74 women who presented to the outpatient clinic and planned to be vaccinated and 30 women who refused to be vaccinated as the control group. Anti-COVID-19 antibody levels in all participants were checked before participation in the study, and participants who were positive were excluded from the study. Blood was taken from the participants in both control and study groups to evaluate their AMH levels before the 2 doses of vaccination. After 2 doses of the vaccine, they were called for follow-up, and serological tests were performed to check whether they were positive for anti-COVID-19 antibodies. Participants in both groups were referred for follow-up after 6 months, samples were taken again for AMH, and the data were recorded. The mean age of the study group was 27.6 ± 5.3 years, and the mean age of the control group was 28.65 ± 5.25 years (P = .298). There was no statistically significant difference between the vaccinated and nonvaccinated groups in terms of AMH levels measured at the 6th month (P = .970). When the vaccinated group was compared in terms of AMH values at the first visit before vaccination and at the 6th month after vaccination, no statistically significant difference was found between them (p:0.127) mRNA vaccination to protect against SARS-CoV-2 does not adversely affect ovarian reserve, which is an indirect indicator of fertility. mRNA vaccines continue to be the most important method of protection against epidemics. Carefully and accurately informing women who are hesitant to get vaccinated is of great importance for the success of the fight against the epidemic. Lippincott Williams & Wilkins 2023-05-17 /pmc/articles/PMC10194489/ /pubmed/37335728 http://dx.doi.org/10.1097/MD.0000000000033824 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 5600
Yildiz, Elif
Timur, Burcu
Guney, Gurhan
Timur, Hakan
Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
title Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
title_full Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
title_fullStr Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
title_full_unstemmed Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
title_short Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
title_sort does the sars-cov-2 mrna vaccine damage the ovarian reserve?
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194489/
https://www.ncbi.nlm.nih.gov/pubmed/37335728
http://dx.doi.org/10.1097/MD.0000000000033824
work_keys_str_mv AT yildizelif doesthesarscov2mrnavaccinedamagetheovarianreserve
AT timurburcu doesthesarscov2mrnavaccinedamagetheovarianreserve
AT guneygurhan doesthesarscov2mrnavaccinedamagetheovarianreserve
AT timurhakan doesthesarscov2mrnavaccinedamagetheovarianreserve